| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | L4766ELH5T |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma | 2 | D002277 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Hepatitis B, Chronic | 2 | D019694 | ClinicalTrials |
| Carcinoma, Basal Cell | 2 | D002280 | ClinicalTrials |
| Ascites | 1 | D001201 | ClinicalTrials |
| Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
| Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298070 |
| FDA SRS | L4766ELH5T |
CONTENTS